forgemax.FORGED. TESTED. PROVEN.
Gain Mix 300mg/ml 10x1ml Ampullen by Omega Meds
Frontload Formula

Gain Mix 300mg/ml 10x1ml Ampullen by Omega Meds

Gain Mix by Omega Meds is a 300mg/ml tri-ester injectable mass blend combining Testosterone Enanthate 100mg, Boldenone Undecylenate 100mg, and Trenbolone Enanthate 100mg per millilitre, engineered specifically to bypass hepatic first-pass metabolism and deliver near-complete systemic bioavailability of all three active esters. Because the formulation relies exclusively on long-acting enanthate and undecylenate chains, blood-level build-up is gradual by design — a structured frontloading approach is used by experienced athletes to accelerate saturation without increasing total cycle dose. Each production batch: independently tested via HPLC for per-compound concentration accuracy across all three APIs before release, presented in 10 single-dose 1ml ampoules for sterile, single-use administration.

€59.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Near-complete systemic bioavailability through intramuscular ester depot — no hepatic first-pass loss
  • Three long-acting esters (Testosterone Enanthate, Boldenone Undecylenate, Trenbolone Enanthate) deliver overlapping anabolic windows from a single weekly injection
  • 300mg/ml concentration supports a structured frontloading dose within one 1ml ampoule
  • Boldenone Undecylenate's 14-day half-life sustains red blood cell stimulation and nutrient delivery throughout the mass phase
  • Trenbolone Enanthate contributes a potent anabolic signal (approximately 5× relative anabolic index) without oral hepatotoxicity risk
  • 10 individual single-dose ampoules ensure clinical sterility at every administration point
  • 3,000mg total active ingredient per box provides full cycle volume in a single purchase

Key takeaways

  • Choose injectable Gain Mix to eliminate first-pass hepatic metabolism entirely.
  • Frontload week one to accelerate long-ester plasma saturation faster.
  • Expect staggered release curves: Tren E peaks first, Bold U sustains longest.
  • Initiate PCT 14–21 days post-cycle once undecylenate clearance window closes.
  • Open each single-dose ampoule immediately before injection for maximum sterility.

Injectable Bioavailability: Why Gain Mix Skips First-Pass Metabolism Entirely

Gain Mix by Omega Meds is a 300mg/ml oil-solution tri-ester injectable — combining Testosterone Enanthate 100mg, Boldenone Undecylenate 100mg, and Trenbolone Enanthate 100mg — formulated specifically to exploit the systemic bioavailability advantage that intramuscular delivery holds over orally administered anabolic compounds. When any of these three active esters is administered by injection, the compound bypasses the hepatic portal circuit completely: esterase-driven hydrolysis releases free steroid directly into systemic circulation, with documented bioavailability approaching 100% for oil-based injectable esters compared to the 10–30% oral bioavailability typically recorded for equivalent non-17α-alkylated compounds that undergo extensive first-pass hepatic extraction before reaching target tissues.

How the Three Esters Build Plasma Levels After Injection

The release kinetics of each ester in Gain Mix are determined by carbon-chain length and enzymatic hydrolysis rate, not by gastrointestinal transit variables that complicate oral dosing. Testosterone Enanthate carries a 7-carbon chain yielding a plasma half-life of approximately 7 days, measured by radioimmunoassay in pharmacokinetic studies. Trenbolone Enanthate, also a 7-carbon chain, clears faster — an estimated 5–7-day effective half-life — meaning it contributes the earliest anabolic signal within the cycle. Boldenone Undecylenate, with its 11-carbon undecylenate chain, releases more slowly, sustaining an approximate 14-day half-life by HPLC-referenced ester hydrolysis modelling; this extended tail underpins both the blend's mass-building consistency and the recommendation to begin PCT approximately 14–21 days after the final injection, with the undecylenate clearance window dictating timing.

Frontloading as the Bioavailability Strategy for Long-Acting Esters

Compared to short-ester injectable blends where plasma peaks arrive within 24–72 hours post-injection, a tri-enanthate/undecylenate stack requires multiple weeks to reach steady-state through standard every-5–7-day injection frequency. Frontloading — administering a higher initial dose in the first week — directly accelerates ester depot saturation and shortens the time-to-therapeutic-plasma-level window without extending total cycle duration. This is the pharmacokinetic rationale behind the Frontload Formula designation: Gain Mix at 300mg/ml provides sufficient concentration per ampoule to execute a structured first-week loading dose within a single 1ml unit, keeping injection volume manageable. Omega Meds packages Gain Mix in 10 single-dose 1ml ampoules, each verified by HPLC for tri-compound accuracy, giving 3,000mg total active ingredient per box under clinical single-use hygiene conditions.

Composition and Administration Summary

Gain Mix delivers Testosterone Enanthate 100mg + Boldenone Undecylenate 100mg + Trenbolone Enanthate 100mg per 1ml ampoule. All three esters achieve systemic bioavailability through intramuscular depot formation and enzymatic de-esterification — a mechanistically cleaner delivery route than oral alternatives subject to cytochrome P450 hepatic extraction. Experienced users implement an aggressive SERM-based PCT protocol, mandatory given trenbolone's progestogenic HPG suppression profile, initiated after the undecylenate clearance window closes.

Usage

  1. Verify ampoule integrity before use — inspect the sealed glass for cracks and confirm the oil solution is clear and free of particulate matter; if any cloudiness or crystallisation is present, warm the ampoule gently in 37°C water until the solution clarifies.
  2. Plan your injection schedule around the ester bioavailability profile — once-weekly or twice-weekly (split dose) administration maintains stable plasma levels given the 5–14-day half-life range across the three esters; mark injection days in advance to avoid unintended gaps.
  3. Snap the ampoule neck at the score line using a sterile gauze pad, then draw the 1ml oil solution using an 18–21-gauge drawing needle — switch to a fresh 23–25-gauge 1–1.5 inch needle for intramuscular injection to minimise tissue trauma.
  4. Select a large muscle site — gluteus maximus or vastus lateralis — with sufficient tissue mass to accommodate the oil depot; administer slowly (30–60 seconds per ml) to distribute the depot evenly and reduce localised pressure.
  5. Rotate injection sites systematically across each cycle — alternating between bilateral glute and quad sites — to prevent repeated-site fibrosis and ensure consistent depot formation for predictable ester release kinetics.
  6. Discard the opened ampoule immediately after use — single-dose ampoules cannot be re-sealed or stored once opened; log each injection date, site, and dose volume to track cumulative exposure and plan the PCT window accurately.

Warnings

Contraindications: Gain Mix is contraindicated in individuals with known hypersensitivity to any of the three active esters or carrier oil components. Not suitable for females due to the virilisation potential of Trenbolone Enanthate and Boldenone Undecylenate. Individuals with active cardiovascular disease, elevated haematocrit, hepatic impairment, or prostate pathology should not use this compound. Not for use by persons under 21.

Side Effects: Testosterone Enanthate undergoes CYP19A1-mediated aromatisation to oestradiol, increasing risk of gynaecomastia and water retention — AI monitoring is advisable. Trenbolone Enanthate does not aromatise but carries progestogenic activity and is associated with night sweats, insomnia, and androgenic alopecia in predisposed individuals. Boldenone Undecylenate stimulates erythropoiesis, and haematocrit should be monitored periodically throughout the cycle to detect polycythaemia before it becomes clinically significant.

Monitoring: Baseline bloodwork before cycle start should include full blood count, haematocrit, liver enzymes (ALT/AST), lipid panel, and total testosterone. Repeat panel at cycle midpoint and at PCT initiation. Blood pressure should be self-monitored weekly — androgenic and oestrogen-related fluid retention can elevate systolic pressure. Haematocrit above physiological range warrants dose adjustment or cycle interruption.

PCT: Due to Trenbolone Enanthate's progestogenic HPG axis suppression combined with Testosterone Enanthate's aromatase-mediated oestradiol feedback, an aggressive SERM-based PCT protocol is mandatory. PCT should begin approximately 14–21 days after the final injection, timed to the Boldenone Undecylenate clearance window as the longest-acting ester in the blend. Prolactin monitoring and potential dopamine agonist inclusion should be assessed based on individual response to the progestogenic component.

Frequently asked questions

Why does injectable Gain Mix have higher bioavailability than oral anabolic compounds with equivalent active ingredients?
Injectable oil-based esters like those in Gain Mix bypass the hepatic portal system entirely, delivering free steroid directly into systemic circulation after enzymatic de-esterification in muscle tissue. Oral non-17α-alkylated androgens are subject to significant first-pass hepatic extraction, reducing effective bioavailability to 10–30% in pharmacokinetic studies, whereas intramuscular ester solutions achieve near-100% systemic availability of the hydrolysed free hormone.
What role does first-pass liver metabolism play in choosing an injectable tri-ester blend over oral mass compounds?
First-pass metabolism occurs when an orally ingested compound passes through the gastrointestinal tract into the hepatic portal vein before reaching systemic circulation, where liver enzymes degrade a significant fraction before it reaches androgen receptors. Injectable esters like Testosterone Enanthate, Boldenone Undecylenate, and Trenbolone Enanthate deposit into an intramuscular oil depot, releasing free steroid through esterase hydrolysis directly into venous circulation — completely avoiding hepatic first-pass degradation.
How does post-injection absorption differ between the three esters in Omega Meds Gain Mix?
Each ester in Gain Mix absorbs at a rate proportional to its carbon-chain length. Trenbolone Enanthate (7-carbon) reaches effective plasma concentrations within days and clears with an estimated 5–7-day half-life. Testosterone Enanthate (7-carbon) follows a similar curve at approximately 7 days. Boldenone Undecylenate (11-carbon) releases most slowly, sustaining plasma levels across roughly 14 days — creating a staggered but continuous anabolic signal from a single injection.
What is the benefit of the single-dose 1ml ampoule format compared to multi-dose vials for a tri-ester like Gain Mix?
Single-dose ampoules eliminate the repeated-puncture contamination risk associated with rubber-stoppered multi-dose vials. Each of the 10 ampoules in a Gain Mix box is a sealed, sterile unit opened immediately before administration, ensuring the oil solution is not exposed to environmental contaminants between doses. This format also prevents concentration drift from draw-to-draw variability in multi-dose containers, making per-injection dosing more precise.
How should Omega Meds Gain Mix 10x1ml ampoules be stored to preserve ester stability across the shelf life?
Gain Mix ampoules should be stored at room temperature between 15–25°C, away from direct light and humidity. Oil-based ester solutions are susceptible to crystallisation if exposed to temperatures below 15°C — gentle warming in warm (not boiling) water will re-dissolve any crystals without degrading the active esters. Once opened, each single-dose ampoule must be used immediately and the remainder discarded; the sealed ampoules should not be pre-opened or stored once the glass is broken. (2) angle_used

Manufacturer

Omega Meds' decision to package Gain Mix exclusively in single-dose 1ml glass ampoules rather than multi-dose vials reflects a deliberate formulation philosophy centred on per-dose integrity. At 300mg/ml across three co-dissolved esters, any container design that permits repeated entry — such as a rubber-stoppered vial — introduces cumulative contamination risk and potential oil-phase disturbance between draws. The ampoule format eliminates both variables: each unit is a hermetically sealed, sterile, single-use vessel that is opened immediately prior to administration, preserving the oil solution in its original, analytically verified state until the moment of use. Omega Meds' quality programme assigns each Gain Mix batch a certificate of analysis documenting per-compound HPLC quantification for all three APIs — Testosterone Enanthate, Boldenone Undecylenate, and Trenbolone Enanthate — confirming that the declared 100mg/ml per-compound split is met within validated tolerance limits before the batch is released for distribution. The 10-ampoule box configuration was also chosen with practical cycle arithmetic in mind: a single box delivers 3,000mg total active ingredient across 10 sterile, precision-filled units, giving athletes a clean per-injection accounting framework without the need to calculate draw volumes from a shared multi-dose reservoir.

Product details

BrandOmega Meds
Active ingredientmix product
Also known asSteroid-Mix, Mehrkomponenten-Mischung, Cut Mix, Gain Mix, Omega Meds Steroid-Mix
Strength300 mg
FormAmpullen
Pack size10 pieces
Item numberINJ-MIX-OME-300-011

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Mixobolin-200 200mg/ml 10x1ml Ampoules by BM PharmaceuticalsHardcore Cutting

Mixobolin-200 200mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€76.00
Mix Products Injection 250mg/ml 10ml Vial by GenesisRecomp Optimizer

Mix Products Injection 250mg/ml 10ml Vial by Genesis

€54.00
NTD 400 400mg/ml 10ml Vial by GenTecMass Building

NTD 400 400mg/ml 10ml Vial by GenTec

€50.00
Cut Stack 150 150mg/ml 10ml Vial by Hilma BiocareBest Value

Cut Stack 150 150mg/ml 10ml Vial by Hilma Biocare

€54.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00